Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Protein kinase domain containing protein | 0.0056 | 0.0072 | 0.013 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Echinococcus granulosus | ribonuclease H1 | 0.058 | 0.2527 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0056 | 0.0072 | 0.0033 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0056 | 0.0072 | 0.013 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0056 | 0.0072 | 0.013 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0091 | 0.0237 | 0.0793 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0629 | 0.2757 | 0.2728 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0629 | 0.2757 | 0.2728 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.058 | 0.2527 | 0.5 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0091 | 0.0237 | 0.0793 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0055 | 0.0065 | 1 |
Giardia lamblia | Ribonuclease H | 0.058 | 0.2527 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Schistosoma mansoni | tyrosine kinase | 0.0056 | 0.0072 | 0.0033 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0041 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Echinococcus multilocularis | 0.005 | 0.0043 | 0.0014 | |
Trypanosoma brucei | ingi protein (ORF1) | 0.0629 | 0.2757 | 0.2728 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0166 | 0.0587 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Echinococcus granulosus | insulin receptor | 0.0056 | 0.0072 | 0.013 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.058 | 0.2527 | 1 |
Trypanosoma brucei | unspecified product | 0.0629 | 0.2757 | 0.2728 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0629 | 0.2757 | 0.2728 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0055 | 0.0065 | 0.5 |
Toxoplasma gondii | ribonuclease HI protein | 0.058 | 0.2527 | 0.5 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0055 | 0.0065 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Mycobacterium ulcerans | hypothetical protein | 0.0055 | 0.0065 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0055 | 0.0065 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.0237 | 0.0198 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0041 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible maturase | 0.0049 | 0.004 | 0.0455 |
Trypanosoma brucei | RNA helicase, putative | 0.2173 | 1 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0055 | 0.0065 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0055 | 0.0065 | 0.074 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0091 | 0.0237 | 0.0793 |
Leishmania major | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0056 | 0.0072 | 0.1229 |
Onchocerca volvulus | 0.0055 | 0.0065 | 0.01 | |
Echinococcus multilocularis | ribonuclease H1 | 0.058 | 0.2527 | 1 |
Trypanosoma brucei | ribonuclease H1 | 0.058 | 0.2527 | 0.2497 |
Schistosoma mansoni | tyrosine kinase | 0.0166 | 0.0587 | 0.055 |
Echinococcus multilocularis | insulin receptor | 0.0056 | 0.0072 | 0.013 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0041 | 0 | 0.5 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0166 | 0.0587 | 0.2202 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0166 | 0.0587 | 0.2202 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0055 | 0.0065 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0227 | 0.0874 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0166 | 0.0587 | 0.2202 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0055 | 0.0065 | 0.074 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.0237 | 0.0198 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.058 | 0.2527 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.